We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAGH:NASDAQMagnitude International Ltd Analysis

Data as of 2026-04-16 - not real-time

$6.76

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Magnitude International Ltd trades at $6.76, exactly on its 20‑day and 50‑day SMA, indicating a flat price action but also a tight support/resistance zone. The RSI of 92 signals extreme overbought conditions while the MACD histogram is negative, a bearish divergence that often precedes a pull‑back. Fundamentals are equally concerning: revenue has slipped -24% year‑over‑year, operating margins are negative (-1.7%) and both operating and free cash flow are deeply in the red. The balance sheet shows a debt‑to‑equity ratio of 389, far above industry norms, and a debt load that dwarfs the modest cash balance. Valuation metrics are out of line, with a price‑to‑book of 478× and a price‑to‑sales of 14.7×, suggesting the market is vastly overvaluing the company. Combined with a historic max drawdown of -75% and a near‑zero 30‑day volatility, the stock appears highly speculative and illiquid.
Given the negative earnings outlook, weak cash generation, and the technical signals pointing to a near‑term correction, the prudent stance is to stay out of MAGH. The negative beta (~‑0.91) implies an inverse move to broader markets, but this hedge is outweighed by the company‑specific risks. Without a clear path to profitability or a dividend, the upside potential is limited while downside risk remains pronounced.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • RSI in extreme overbought territory
  • Bearish MACD divergence
  • Severe overvaluation (PB 478×)

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued revenue decline and negative margins
  • High debt‑to‑equity ratio
  • Lack of cash flow generation

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Structural financial weakness
  • No dividend or earnings visibility
  • Thin trading volume and liquidity risk

Key Metrics & Analysis

Financial Health

Revenue Growth-23.90%
Profit Margin0.28%
ROE3.37%
ROA0.53%
Debt/Equity389.77
P/B Ratio478.3
Op. Cash Flow$-926041
Free Cash Flow$-465392
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI92.2
Support$6.76
Resistance$6.76
MA 20$6.76
MA 50$6.76
MA 200$4.52
MACDBearish
VolumeStable
Fear & Greed Index88.98

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.91
0
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.